Dr. Reddy's Laboratories outperforms competitors despite losses on the day
Dr. Reddy's Laboratories Ltd. closed 16.92% below its 52-week high of 1,420.20 rupees, which the company reached on August ...
Dr. Reddy's Laboratories falls Monday, underperforms market
Dr. Reddy's Laboratories Ltd. 500124 shares slipped 2.23% to 1,197.40 Indian rupees Monday, on what proved to be an ...
Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...
Dr Reddy's Laboratories Ltd (RDY) reports a robust 16% YoY revenue growth, driven by strategic product launches and market ...
Dr Reddy's Laboratories CEO: 'very positive outlook' for Indian pharma industry despite Trump 2.0
CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...
Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Call Transcript January 23, 2025 Operator: Ladies and gentlemen, good day and welcome to the Quarter Three ...
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories sees a modest price increase
Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...
Barclays Reaffirms Their Buy Rating on Dr Reddy’s Laboratories (RDY)
Barclays analyst Balaji Prasad maintained a Buy rating on Dr Reddy’s Laboratories (RDY – Research Report) today and set a price target of ...
Crossmark Global Holdings Inc. Acquires 9,781 Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY)
Crossmark Global Holdings Inc. grew its stake in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 328.3% in the fourth quarter, Holdings Channel reports. The firm owned 12,760 ...
Dr Reddys Share Price Highlights: Dr. Reddy's Laboratories ends the day at Rs 1289.4
Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...
rediff.com2d
Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects
Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after ...
Dr. Reddy's Laboratories shares fall over 6% post subdued Q3 show; analysts divided
Dr. Reddy's shares in Friday's trade saw a sharp fall following the company's weak set of earnings for the December quarter.
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Dr. Reddy's Laboratories Ltd (NYSE:RDY) stock is trading lower after the company released third-quarter 2025 earnings. The pharma company clocked a net income of $165 million, marginally up from $161 ...